Eli Lilly (LLY) PT Raised to $420 at Credit Suisse
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,156.73 -1.52%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
Credit Suisse analyst Trung Huynh raised the price target on Eli Lilly (NYSE: LLY) to $420.00 (from $400.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Lilly reports one-year data on Taltz and Zepbound combined in psoriatic disease
- Goldman Sachs Downgrades Mitsubishi Gas Chemical Co Inc (4182:JP) to Neutral
- Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
